Do human cancers express shared protective antigens? or The necessity of remembrance of things past

Seminars in Immunology

Volumn 8, Issue 5, 1996, Pages 295-302

  Srivastava, Pramod K ^a  

^a FORDHAM UNIVERSITY   (United States)

Author keywords

Antigen; CTL; Human; Melanoma

Indexed keywords

ONCOPROTEIN; TUMOR ANTIGEN;

CANCER IMMUNOLOGY; CYTOTOXIC T LYMPHOCYTE; HUMAN; MELANOMA; MOUSE; NONHUMAN; RAT; REVIEW;

EID: 0030272588     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1996.0038     Document Type: Review

References (47)

1. 1. Boon T, van der Bruggen P (1996) Human tumor antigens recognized by T lymphocytes. J Exp Med 183:725-729
2. 2. Old LJ (1985) Tumor necrosis factor. Science 230:630-632
3. 3. Old LJ (1981) Cancer immunology: the search for specificity -GHA Clowes Memorial Lecture. Cancer Res 41:361-375
4. 4. Darrow TL, Slingluff Jr CL, Siegler HF (1989) The role of HLAclass I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes: evidence for shared tumor antigens. J Immunol 142:3329
5. 5. Kawakami Y, Zakut R, Topalian SL, Stotter H, Rosenberg SA (1992) Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2. 1-transfected melanomas. J Immunol 148:638-643
6. 6. Van den Eynde B, Lethe B, Van Pel A, DePlaen E, Boon T (1991) The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/ 2. J Exp Med 173:1373-1384
7. 7. Ramarathinam L, Sarma S, Maric M, Zhao M, Yang G, Chen L, Liu Y (1995) Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross protected. J Immunol 155:5323
8. 8. Finn OJ, Jerome KR, Henderson RA, Pecher G, Domenech N, Magarian-Blander J, Barratt-Boyes SM (1995) MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. Immunol Rev 145:61-89
9. 9. Santos E, Tronick SR, Aaronson SA, Pulciani S, Barbacid M (1982) T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB-and Harvey-MSV transforming genes. Nature 298:343-347
10. 10. Noguchi Y, Chen YT, Old LJ (1994) A mouse mutant p53 product recognized by CD4+ and CD8+ T cells. Proc Natl Acad Sci USA 91:3171-3175
11. 11. Cheever MA, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, Qin HL, Takahashi M, Chen W (1995) Immunity to oncogenic proteins. Immunol Rev 145:33-59
12. 12. Gjertsen MK, Bakka A, Breivik J, Saeterdal I, Solheim BG, Soreide O, Thorsby E, Gaudernack G (1995) Vaccination with mutant ras peptide and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation. Lancet 346:1399-1400
13. 13. Robbins PF, El-Gamil M, Li YF, Topalian SL, Rivoltini L, Sakaguchi K, Apella E, Kawakami Y, Rosenberg SA (1995) Cloning of a new gene encoding an antigen recognized by melanoma-specific antigen recognized by melanoma-specific HLA-A22-restricted tumor infiltrating lymphocytes. J Immunol 154:5944-5950
14. 14. Rohrer JW, Rohrer SD, Barsoum A, Coggin Jr JH (1994) Differential recognition of murine tumor - associated oncofetal transplantation antigen and individually specific transplantation antigens by syngeneic cloned BALB/ c and RFM mouse T cells. J Immunol 152:754
15. d cytolytic T cells. Cell 58:293
16. 16. Marchand M, Weynants P, Rankin E, Arienti F, Belli F, Parmani G, Cascinelli N, Bourlond A, Vanwijck R, Humblet Y, Canon J-L, Laurent C, Naeyaert J-M, Plagne R, Deraemaeker R, Knuth A, Jager E, Brasseur F, Herman J, Coulie PG, Boon T (1996) Letter to the editor: Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer 63:883-885
17. 17. Jaeger, Bernhard H, Romero P, Ringhoffer M, Arand M, Karbarch J, Ilsemann C, Hagedorn M, Knuth A (1996) Generation of cytotoxic T cell response with synthetic melanoma associated peptides in vivo: Implications for tumor vaccines with melanoma associated antigens. Int J Cancer 66:162-169
18. 18. Gross L (1943) Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line. Cancer Res 3:326-333
19. 19. Baldwin RW (1955) Br J Cancer 9:652-657
20. 20. Prehn RT, Main JM (1957) Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst 18:769
21. 21. Klein G, Sjogren HO, Klein E, et al (1960) Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res 20:1561-1572
22. 22. Old LJ, Boyse EA, Clarke DA, Carswell EA (1962) Antigenic properties of chemically induced tumors. Ann NY Acad Sci 101:80
23. 23. Globerson A, Feldman M (1964) Antigenic specificity of benzo(a)pyrene induced sarcomas. J Natl Cancer Inst 32:1229
24. 24. Basombrío MA (1970) Search for common antigenicities among 25 sarcomas induced by methylcholanthrene. Cancer Res 30:2458
25. 25. Morton DL, Miller GF, Wood DA (1993) Demonstration of tumor specific immunity against antigens unrelated to the mammary tumor virus in spontaneous mammary adenocarcinomas, in Fundamental Immunology Paul Wed. Raven Press, New York
26. 26. Carswell EA, Wanebo HJ, Old LJ, Boyse EA (1993) Immunogenic properties of reticulum cell sarcomas of SJL/ J mice, in Fundamental Immunology Paul W, ed. Raven Press, New York
27. 27. Koch S, Zaleberg JR, McKenzie IFC (1993) Description of a murine B lymphoma tumor-specific antigen, in Fundamental Immunology Paul W, ed. Raven Press, New York
28. 28. Porgador A, Bannerji R, Watanabe Y, Feldman M, Gilboa E, Eisenbach L (1993) Antimetastatic vaccination of tumor-bearing mice with two types of IFN-g gene inserted tumor cells. J Immunol 150:1458-1470
29. 29. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage-colony-stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539-3543
30. 30. Srivastava PK, Old LJ (1988) Individually distinct transplantation antigens of chemically induced mouse tumors. Immunol Today 9:78
31. 31. Coggin JH (1986) Oncofetal antigens. Nature 319:428
32. 32. Rashid H, Barsoum AL, Cao TM, Coggin JH (1994) Identification of partial complementary DNA clones encoding a 59-kd protein with characteristics of a unique oncofetal antigen. J Natl Cancer Inst 86:515-526
33. 33. Srivastava PK (1993) Peptide - binding heat shock proteins in the endoplasmic reticulum: Role in immune response to cancer and in antigen presentation. Adv Cancer Res 62:153
34. 34. Sahasrabudhe DM, Burstyn D, Dusel JC, Hibner BL, Collins JL, Zauderer M (1993) Shared T cell-defined antigens on independently derived tumors. J Immunol 11:6302-6310
35. 35. Basombrio MA, Prehn RT (1972) Antigenic diversity of tumors chemically induced within the progeny of a single cell. Int J Cancer 10:1
36. 36. Stephenson JR, Aaronson SA (1972) Antigenic properties of murine sarcoma virus-transformed BALB-3T3 nonproducer cells. J Exp Med 135:503-515
37. 37. Shu S, Chou T, Rosenberg SA (1986) Cancer Res 47:1354-1360
38. 38. Yoshizawa H, Chang AE, Shu S (1992) Cancer Res 52:1129-1136
39. 39. Udono H, Levey DL, Srivastava PK (1994) Definition of T cell sub-sets mediating tumor - specific immunogenicity of cognate heat shock protein gp96. Proc Natl Acad Sci USA 91:3077
40. 40. Levraud JP, Pannetier C, Langlade-Demoyen, Brichard V, Kourilsky P (1996) Recurrent T cell receptor rearrangements in the cytotoxic T lymphocyte response in vivo against the p815 murine tumor. J Exp Med 183:439-449
41. 41. Salgaller ML, Afshar A, Marincola FM, Rivoltini L, Rosenberg YA (1995) Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides. Cancer Res 21:4972-4979
42. 42. Mandelboim O, Vadai E, Fridkin M, Katz-Hillel A, Feldman M, Berke G, Eisenbach L (1995) Nature Med 1:1179-1183
43. 43. Huang AYC, Gulden PH, Woods AS, Thomas MC, Tong CD, Wang W, Engelhard VH, Pasternack G, Cotter R, Hunt D, Pardoll D, Jaffe E (1996) The immunodominant MHC class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc Natl Acad Sci USA, in press
44. 44. Uttenhove C, Maryanski J, Boon T (1983) Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. J Exp Med 157:1040-1052
45. 45. North RJ, Bursuker I (1984) Generation and decay of the immune response to a progressive fibrosarcoma, Ly-1+2-suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells. J Exp Med 159:1295-1311
46. 46. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666-3670
47. 47. Knuth A, Danowski B, Oettgen HF, Old LJ (1984) T-/ cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin-2 dependent T cell cultures. Proc Natl Acad Sci USA 11:3511-3515